Pediatric Onset Myelin Oligodendrocyte Glycoprotein-Associated Disease: A Series of Four Cases
Keywords:
children, myelin-oligodendrocyte glycoprotein, myelin oligodendrocyte glycoprotein antibody-associated disease.Abstract
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD) is a rare inflammatory demyelinating disease of the central nervous system with monophasic and relapsing manifestations. The most common presenting phenotypes of MOG-AD in pediatric population include acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), transverse myelitis (TM) and brainstem syndromes. Here, we report four cases of MOG-AD in pediatric patients. Patients presented with headache, gait disorder, dysarthria, seizure. The first case had weakness of both lower limbs with irritability, 2nd case had altered conscious level with seizure along with walking and speech difficulty. The 3rd case had relapsing features, visual and speech problem with optic neuritis after 2 years of treatment. The 4th case had headache and unsteady gait, visual impairment and speech difficulty. Most of the patients had demyelinating features in magnetic resonance imaging (MRI) of brain. All the four cases were positive for anti-MOG antibody. Treatment was done according to the protocol of the institute with steroid, intravenous immunoglobulin and rituximab.
J Bangladesh Coll Phys Surg 2026; 44: 198-203
13
9
Downloads
Published
How to Cite
Issue
Section
License
Submission of a manuscript for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted manuscripts become the permanent property of the Journal of Bangladesh College of Physicians and Surgeons and may not be reproduced by any means in whole or in part without the written consent of the publisher.
No part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in the Journal will be available from the publisher.